Adma Biologics Inc (ADMA): Next-Year EPS Estimate 28.06%
As of 2026-06-10, Adma Biologics Inc (ADMA) has a next-year EPS growth estimate of 28.06%.
On 2026-05-10, analyst consensus for ADMA's next-year EPS growth shifted from 27.94% to 28.06% — a positive change of 0.12 percentage points. The revised estimate has been sustained across 24 subsequent trading sessions. Current-year growth is projected at 28.41%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.06%
- EPS growth this year
- 28.41%
- EPS next quarter (est)
- $0.19
- Last price
- $8.69
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-10 | 28.06% | 28.41% | $0.19 | $8.69 |
| 2026-06-09 | 28.06% | 28.41% | $0.19 | $8.12 |
| 2026-06-08 | 28.06% | 28.41% | $0.19 | $8.06 |
| 2026-06-07 | 28.06% | 28.41% | $0.19 | $7.97 |
| 2026-06-04 | 28.06% | 28.41% | $0.19 | $7.98 |
| 2026-06-03 | 28.06% | 28.41% | $0.19 | $7.76 |
| 2026-06-02 | 28.06% | 28.41% | $0.19 | $7.60 |
| 2026-06-01 | 28.06% | 28.41% | $0.19 | $7.90 |
| 2026-05-31 | 28.06% | 28.41% | $0.19 | $7.98 |
| 2026-05-28 | 28.06% | 28.41% | $0.19 | $7.93 |
| 2026-05-27 | 28.06% | 28.41% | $0.19 | $7.92 |
| 2026-05-26 | 28.06% | 28.41% | $0.19 | $8.15 |
| 2026-05-25 | 28.06% | 28.41% | $0.19 | $8.24 |
| 2026-05-24 | 28.06% | 28.41% | $0.19 | $8.24 |
| 2026-05-21 | 28.06% | 28.41% | $0.19 | $8.46 |
| 2026-05-20 | 28.06% | 28.41% | $0.19 | $8.56 |
| 2026-05-19 | 28.06% | 28.41% | $0.19 | $8.63 |
| 2026-05-18 | 28.06% | 28.41% | $0.19 | $8.38 |
| 2026-05-17 | 28.06% | 28.41% | $0.19 | $8.27 |
| 2026-05-14 | 28.06% | 28.41% | $0.19 | $8.50 |
| 2026-05-13 | 28.06% | 28.41% | $0.19 | $8.45 |
| 2026-05-12 | 28.06% | 28.41% | $0.19 | $8.41 |
| 2026-05-11 | 28.06% | 28.41% | $0.19 | $7.88 |
| 2026-05-10 | 28.06% | 28.41% | $0.19 | $8.17 |
| 2026-05-07 | 27.94% | 28.61% | $0.19 | $8.47 |
| 2026-05-06 | 34.97% | 45.16% | $0.19 | $10.08 |
| 2026-05-05 | 34.97% | 45.16% | $0.19 | $10.25 |
| 2026-05-04 | 34.97% | 45.16% | $0.19 | $10.31 |
| 2026-05-03 | 34.97% | 45.16% | $0.19 | $10.52 |
| 2026-04-30 | 34.97% | 45.16% | $0.19 | $10.25 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Adma Biologics Inc's next-year EPS growth estimate?▾
As of 2026-06-10, Adma Biologics Inc (ADMA) has a next-year EPS growth estimate of 28.06%, based on analyst consensus.
When was the latest EPS estimate revision for ADMA?▾
The most recent revision occurred on 2026-05-10, when analysts adjusted the next-year EPS growth estimate from 27.94% to 28.06%.
What sector and industry does Adma Biologics Inc belong to?▾
Adma Biologics Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ADMA appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Adma Biologics Inc (ADMA) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports